Bristol-Myers Experimental Cocktail Bests Hepatitis C Treatment

[Guest guest]

Bristol-Myers Experimental Cocktail Bests Hepatitis C Treatment

Without pegylated interferon, experimental drugs by Bristol-Myers Squibb appear to be on the path of improving Hepatitis C treatment - by making it easier to endure and increasing the success rate.

Bristol-Myers Interferon-Free Combo Cured Hepatitis Patients

By Naomi Kresge - Apr 2, 2011

Bristol-Myers Squibb Co. (BMY)'s cocktail of two experimental drugs cured four hepatitis C patients in the first success for a therapy that excludes often-toxic existing drugs.

The combination had a higher rate of success when paired with the current standard treatment in the 21-person trial, curing nine of 10 patients, researchers said today at the Berlin meeting of the European Association for the Study of the Liver. The study points to the next generation of drugs for the evasive virus, said Mark Thursz, a professor of hepatology at Imperial College London and vice-secretary of EASL.

Continue reading this entire article:http://www.bloomberg.com/news/2011-04-02/bristol-myers-interferon-free-combo-cured-hepatitis-c-patients.html

http://www.hepatitis-central.com/mt/archives/2011/04/bristol-myers_e.html